News & Topics

2015.02.17 Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells

Stemgent, a ReproCELL Group Company and Transposagen Biopharmaceuticals enter into a service partnership agreement providing genetically engineered stem cells

2015.02.16 Additional Explanation regarding 3Q FY March 2015 Consolidated Financial Results

Additional Explanation regarding 3Q FY March 2015 Consolidated Financial Results

2015.02.09 ReproCELL Launches Global Sales Collaboration with Revive Organtech, INC.

ReproCELL Launches Global Sales Collaboration with Revive Organtech, INC.

2015.02.04 BioServe 25th Anniversary Message

BioServe 25th Anniversary Message

2015.02.02 ReproCELL Launches Sales Collaboration with DreamCell Co., Ltd. in Republic of Korea

ReproCELL Launches Sales Collaboration with DreamCell Co., Ltd. in Republic of Korea

2015.01.27 A national patent on culture method of hematopoietic stem cell was approved

A national patent on culture method of hematopoietic stem cell was approved

2014.11.04 Commencement of mutual sales of products from the ReproCELL group companies

Commencement of mutual sales of products from the ReproCELL group companies

2014.10.03 ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Completed the Acquisition of iPS Cell Business Unit of Stemgent, Inc.(PDF)

2014.09.29 ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited

ReproCELL Launches the Operation of Cell Innovation Partners, L.P., Corporate Venture Capital Fund, with Shinsei Bank, Limited

2014.09.08 ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.